TELINTRA® (Ezatiostat HCl) A small molecule bone marrow stimulant that is in a Phase 2 trial in myelodysplastic syndrome (MDS) and severe chronic idiopathic neutropenia (SCN).
TELCYTA® (Canfosfamide HCl) A cancer cell-activated small molecule that is in development for ovarian and non-small cell lung cancer.
Preclinical Pipeline Additional potential product candidates in our pipeline have resulted from our ongoing discovery research programs and our collaborations with leading cancer centers. These include a tetravalent alkylator, inhibitors of enzymes we believe are critical to the growth of cancer cells, and other compounds directed toward critical cancer cell growth mechanisms.
$0.8203 (10/21/09)
